GlassScriptPhysician profile
Kevin Crawford
NPI 1336242577
$602.18
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.71 · 2020: $46.82 · 2021: $231 · 2023: $142 · 2024: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $353.95 | 2020-2024 | Mako, Alphavent |
| Depuy Synthes Sales INC. | $86.51 | 2021-2024 | Monovisc |
| Abbott Laboratories | $44.87 | 2024 | Proclaim |
| Mallinckrodt Enterprises LLC | $30.66 | 2019 | |
| Pacira Therapeutics, INC. | $25.12 | 2019-2021 | |
| Baudax Bio INC. | $22.76 | 2021 | |
| Vericel Corporation | $21.77 | 2024 | Maci |
| Orthofix Medical, INC. | $16.54 | 2024 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.